Email
Print
Psoriasis Therapeutics Market - Forecast(2024 - 2030)
1. Psoriasis Therapeutics Market - Overview
1.1 Definitions and Scope
2. Psoriasis Therapeutics Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Psoriasis Therapeutics Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Psoriasis Therapeutics Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Psoriasis Therapeutics Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Psoriasis Therapeutics Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Psoriasis Therapeutics Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Psoriasis Therapeutics Market - By Drug Class (Market Size -$Million / $Billion)
8.1 Tnf Inhibitor
8.2 Pde4 Inhibitor
8.3 Interleukin Blocker
9. Psoriasis Therapeutics Market - By Molecule Type (Market Size -$Million / $Billion)
9.1 Biologics
9.2 Small Molecule
10. Psoriasis Therapeutics - By Route Of Administration (Market Size -$Million / $Billion)
10.1 Oral
10.2 Parenteral
10.3 Topical
11. Psoriasis Therapeutics- By Geography (Market Size -$Million / $Billion)
11.1 Psoriasis Therapeutics Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Psoriasis Therapeutics- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Psoriasis Therapeutics- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Psoriasis Therapeutics - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Psoriasis Therapeutics - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Psoriasis Therapeutics Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Psoriasis Therapeutics Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Psoriasis Therapeutics Market - Key Company List by Country Premium
15. Psoriasis Therapeutics Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Astellas Pharma Inc
15.3 Astrazeneca Plc
15.4 Biocon Limited
15.5 Boehringer Ingelheim Gmbh
15.6 Eli Lilly And Company
15.7 F. Hofffmann-La Roche
15.8 G W Laboratory Inc
15.9 Glaxosmithkline Plc
15.10 Lamea
15.11 Merck Co , Inc
15.12 Valeant Pharmaceutical International, Inc
15.13 Company 13
15.14 Company 14 & More
16.1 Abbreviations
16.2 Sources
17. Psoriasis Therapeutics Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Psoriasis Therapeutics Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Psoriasis Therapeutics Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Psoriasis Therapeutics Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Psoriasis Therapeutics Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Psoriasis Therapeutics Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Psoriasis Therapeutics Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Psoriasis Therapeutics Market - By Drug Class (Market Size -$Million / $Billion)
8.1 Tnf Inhibitor
8.2 Pde4 Inhibitor
8.3 Interleukin Blocker
9. Psoriasis Therapeutics Market - By Molecule Type (Market Size -$Million / $Billion)
9.1 Biologics
9.2 Small Molecule
10. Psoriasis Therapeutics - By Route Of Administration (Market Size -$Million / $Billion)
10.1 Oral
10.2 Parenteral
10.3 Topical
11. Psoriasis Therapeutics- By Geography (Market Size -$Million / $Billion)
11.1 Psoriasis Therapeutics Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Psoriasis Therapeutics- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Psoriasis Therapeutics- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Psoriasis Therapeutics - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Psoriasis Therapeutics - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Psoriasis Therapeutics Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Psoriasis Therapeutics Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Psoriasis Therapeutics Market - Key Company List by Country Premium
15. Psoriasis Therapeutics Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Astellas Pharma Inc
15.3 Astrazeneca Plc
15.4 Biocon Limited
15.5 Boehringer Ingelheim Gmbh
15.6 Eli Lilly And Company
15.7 F. Hofffmann-La Roche
15.8 G W Laboratory Inc
15.9 Glaxosmithkline Plc
15.10 Lamea
15.11 Merck Co , Inc
15.12 Valeant Pharmaceutical International, Inc
15.13 Company 13
15.14 Company 14 & More
*Financials would be provided on a best efforts basis for private companies
16. Psoriasis Therapeutics Market - Appendix16.1 Abbreviations
16.2 Sources
17. Psoriasis Therapeutics Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Global Psoriasis Therapeutic Market, By Drug Class Market 2023-2030 ($M)1.1 Tnf Inhibitor Market 2023-2030 ($M) - Global Industry Research
1.2 Pde4 Inhibitor Market 2023-2030 ($M) - Global Industry Research
1.3 Interleukin Blocker Market 2023-2030 ($M) - Global Industry Research
2.Global Global Psoriasis Therapeutic Market, By Molecule Type Market 2023-2030 ($M)
2.1 Biologics Market 2023-2030 ($M) - Global Industry Research
2.2 Small Molecule Market 2023-2030 ($M) - Global Industry Research
3.Global Global Psoriasis Therapeutic Market, By Route Of Administration Market 2023-2030 ($M)
3.1 Oral Market 2023-2030 ($M) - Global Industry Research
3.2 Parenteral Market 2023-2030 ($M) - Global Industry Research
3.3 Topical Market 2023-2030 ($M) - Global Industry Research
4.Global Global Psoriasis Therapeutic Market, By Drug Class Market 2023-2030 (Volume/Units)
4.1 Tnf Inhibitor Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Pde4 Inhibitor Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Interleukin Blocker Market 2023-2030 (Volume/Units) - Global Industry Research
5.Global Global Psoriasis Therapeutic Market, By Molecule Type Market 2023-2030 (Volume/Units)
5.1 Biologics Market 2023-2030 (Volume/Units) - Global Industry Research
5.2 Small Molecule Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global Global Psoriasis Therapeutic Market, By Route Of Administration Market 2023-2030 (Volume/Units)
6.1 Oral Market 2023-2030 (Volume/Units) - Global Industry Research
6.2 Parenteral Market 2023-2030 (Volume/Units) - Global Industry Research
6.3 Topical Market 2023-2030 (Volume/Units) - Global Industry Research
7.North America Global Psoriasis Therapeutic Market, By Drug Class Market 2023-2030 ($M)
7.1 Tnf Inhibitor Market 2023-2030 ($M) - Regional Industry Research
7.2 Pde4 Inhibitor Market 2023-2030 ($M) - Regional Industry Research
7.3 Interleukin Blocker Market 2023-2030 ($M) - Regional Industry Research
8.North America Global Psoriasis Therapeutic Market, By Molecule Type Market 2023-2030 ($M)
8.1 Biologics Market 2023-2030 ($M) - Regional Industry Research
8.2 Small Molecule Market 2023-2030 ($M) - Regional Industry Research
9.North America Global Psoriasis Therapeutic Market, By Route Of Administration Market 2023-2030 ($M)
9.1 Oral Market 2023-2030 ($M) - Regional Industry Research
9.2 Parenteral Market 2023-2030 ($M) - Regional Industry Research
9.3 Topical Market 2023-2030 ($M) - Regional Industry Research
10.South America Global Psoriasis Therapeutic Market, By Drug Class Market 2023-2030 ($M)
10.1 Tnf Inhibitor Market 2023-2030 ($M) - Regional Industry Research
10.2 Pde4 Inhibitor Market 2023-2030 ($M) - Regional Industry Research
10.3 Interleukin Blocker Market 2023-2030 ($M) - Regional Industry Research
11.South America Global Psoriasis Therapeutic Market, By Molecule Type Market 2023-2030 ($M)
11.1 Biologics Market 2023-2030 ($M) - Regional Industry Research
11.2 Small Molecule Market 2023-2030 ($M) - Regional Industry Research
12.South America Global Psoriasis Therapeutic Market, By Route Of Administration Market 2023-2030 ($M)
12.1 Oral Market 2023-2030 ($M) - Regional Industry Research
12.2 Parenteral Market 2023-2030 ($M) - Regional Industry Research
12.3 Topical Market 2023-2030 ($M) - Regional Industry Research
13.Europe Global Psoriasis Therapeutic Market, By Drug Class Market 2023-2030 ($M)
13.1 Tnf Inhibitor Market 2023-2030 ($M) - Regional Industry Research
13.2 Pde4 Inhibitor Market 2023-2030 ($M) - Regional Industry Research
13.3 Interleukin Blocker Market 2023-2030 ($M) - Regional Industry Research
14.Europe Global Psoriasis Therapeutic Market, By Molecule Type Market 2023-2030 ($M)
14.1 Biologics Market 2023-2030 ($M) - Regional Industry Research
14.2 Small Molecule Market 2023-2030 ($M) - Regional Industry Research
15.Europe Global Psoriasis Therapeutic Market, By Route Of Administration Market 2023-2030 ($M)
15.1 Oral Market 2023-2030 ($M) - Regional Industry Research
15.2 Parenteral Market 2023-2030 ($M) - Regional Industry Research
15.3 Topical Market 2023-2030 ($M) - Regional Industry Research
16.APAC Global Psoriasis Therapeutic Market, By Drug Class Market 2023-2030 ($M)
16.1 Tnf Inhibitor Market 2023-2030 ($M) - Regional Industry Research
16.2 Pde4 Inhibitor Market 2023-2030 ($M) - Regional Industry Research
16.3 Interleukin Blocker Market 2023-2030 ($M) - Regional Industry Research
17.APAC Global Psoriasis Therapeutic Market, By Molecule Type Market 2023-2030 ($M)
17.1 Biologics Market 2023-2030 ($M) - Regional Industry Research
17.2 Small Molecule Market 2023-2030 ($M) - Regional Industry Research
18.APAC Global Psoriasis Therapeutic Market, By Route Of Administration Market 2023-2030 ($M)
18.1 Oral Market 2023-2030 ($M) - Regional Industry Research
18.2 Parenteral Market 2023-2030 ($M) - Regional Industry Research
18.3 Topical Market 2023-2030 ($M) - Regional Industry Research
19.MENA Global Psoriasis Therapeutic Market, By Drug Class Market 2023-2030 ($M)
19.1 Tnf Inhibitor Market 2023-2030 ($M) - Regional Industry Research
19.2 Pde4 Inhibitor Market 2023-2030 ($M) - Regional Industry Research
19.3 Interleukin Blocker Market 2023-2030 ($M) - Regional Industry Research
20.MENA Global Psoriasis Therapeutic Market, By Molecule Type Market 2023-2030 ($M)
20.1 Biologics Market 2023-2030 ($M) - Regional Industry Research
20.2 Small Molecule Market 2023-2030 ($M) - Regional Industry Research
21.MENA Global Psoriasis Therapeutic Market, By Route Of Administration Market 2023-2030 ($M)
21.1 Oral Market 2023-2030 ($M) - Regional Industry Research
21.2 Parenteral Market 2023-2030 ($M) - Regional Industry Research
21.3 Topical Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)2.Canada Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
3.Mexico Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
4.Brazil Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
5.Argentina Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
6.Peru Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
7.Colombia Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
8.Chile Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
9.Rest of South America Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
10.UK Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
11.Germany Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
12.France Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
13.Italy Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
14.Spain Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
15.Rest of Europe Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
16.China Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
17.India Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
18.Japan Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
19.South Korea Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
20.South Africa Psoriasis Therapeutics Market Revenue, 2023-2030 ($M)
21.North America Psoriasis Therapeutics By Application
22.South America Psoriasis Therapeutics By Application
23.Europe Psoriasis Therapeutics By Application
24.APAC Psoriasis Therapeutics By Application
25.MENA Psoriasis Therapeutics By Application
26.Astellas Pharma Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Astrazeneca Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.North America, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Boehringer Ingelheim Gmbh, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Europe, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Asia-Pacific, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.F. Hofffmann-La Roche, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Lamea, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Merck Co , Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
36.Valeant Pharmaceutical International, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
37.Biocon Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
38.Eli Lilly And Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
39.G W Laboratory Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)